Intellia Therapeutics Inc... (NTLA)
NASDAQ: NTLA
· Real-Time Price · USD
10.99
0.09 (0.83%)
At close: Aug 15, 2025, 3:59 PM
11.01
0.18%
After-hours: Aug 15, 2025, 07:57 PM EDT
Intellia Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 156.17M | 126.88M | 189.18M | 120.5M | 130.85M | 171.98M | 226.75M | 168.03M | 171.81M | 294.15M | 523.51M | 141.19M | 147.78M | 133.38M | 123.41M | 334.74M | 129.88M | 141.54M |
Short-Term Investments | 303.48M | 376.87M | 412.33M | 537.62M | 560.22M | 619.32M | 685.48M | 686.76M | 736.27M | 639.39M | 669.12M | 687M | 726.49M | 721.87M | 625.28M | 463.53M | 399.14M | 442.52M |
Long-Term Investments | 196.94M | 228.1M | 304.48M | 316.52M | 262.41M | 175.69M | 154.51M | 197.28M | 41.03M | 294.35M | 142.32M | 97.62M | 115.35M | 227.25M | 425.05M | 413.29M | 22.26M | 16.73M |
Other Long-Term Assets | 17.33M | 16.77M | n/a | 16.84M | 36.23M | 57.35M | n/a | n/a | 185.85M | n/a | n/a | n/a | n/a | n/a | n/a | 5.17M | 4.98M | 5M |
Receivables | 11.35M | 10.5M | 8.52M | 8.85M | 12.33M | 36.43M | 36.46M | 6.49M | 5.06M | 4.91M | 3.77M | 4.02M | 2.85M | 1.8M | 2.03M | 2.49M | 1.99M | 953K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -137.75M | -164.01M | -225.04M | -69.34M | n/a | -32.6M | n/a | -337.36M | n/a | n/a | n/a |
Other Current Assets | 24.94M | 37.14M | 29.83M | 43.93M | 53.81M | 56.32M | 49.65M | 169.97M | 26.48M | 25.22M | 20.41M | 26.73M | 18.3M | 18.32M | 18.58M | n/a | 18.39M | 16.07M |
Total Current Assets | 495.94M | 551.39M | 639.86M | 710.9M | 757.21M | 884.04M | 998.33M | 893.49M | 939.62M | 963.67M | 1.22B | 858.95M | 895.43M | 875.37M | 769.3M | 814.77M | 549.4M | 601.08M |
Property-Plant & Equipment | 188.68M | 189.91M | 246.67M | 129.09M | 135.69M | 142.5M | 148.13M | 152.57M | 156.74M | 159.87M | 161M | 127.89M | 99.64M | 100.17M | 100.11M | 101.73M | 95.6M | 94.07M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 402.95M | 434.77M | 551.15M | 462.45M | 434.32M | 375.55M | 302.65M | 349.86M | 383.63M | 454.22M | 303.32M | 225.51M | 214.99M | 327.42M | 525.16M | 520.19M | 122.84M | 115.81M |
Total Assets | 898.89M | 986.16M | 1.19B | 1.17B | 1.19B | 1.26B | 1.3B | 1.24B | 1.32B | 1.42B | 1.52B | 1.08B | 1.11B | 1.2B | 1.29B | 1.33B | 672.24M | 716.89M |
Account Payables | 9.8M | 12.36M | 14.59M | 13.14M | 18.82M | 13.69M | 7.45M | 3.55M | 11.63M | 6.89M | 5.15M | 4.38M | 7.51M | 10.14M | 9.65M | 7.47M | 6.85M | 8.69M |
Deferred Revenue | 17.15M | 20.66M | 20.66M | 22.16M | 22.18M | 22.18M | 22.14M | 13.35M | 21.93M | 35.34M | 43.84M | 54.82M | 61.81M | 63.76M | 63.76M | 56.76M | 22.54M | 22.54M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | 18.76M | 18.6M | 17.07M | 16.75M | 16.33M | n/a | 13.55M | 9.57M | 9.34M | 9.11M | 8.71M | 7.42M | 8.26M |
Other Current Liabilities | 12.4M | 9.85M | 24.07M | 51.21M | 30.23M | 14.13M | 21.8M | 19.9M | 17.07M | 18.43M | 39.1M | 26.91M | 22.42M | 22.39M | 13.84M | 4.1M | 19.7M | 6.72M |
Total Current Liabilities | 95.5M | 112.59M | 110.85M | 105.68M | 105.09M | 97.91M | 115.21M | 91.95M | 99.85M | 103.38M | 126.55M | 131.13M | 123.76M | 126.11M | 125.83M | 97.57M | 73.96M | 60.7M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 33.44M | 38.85M | n/a | n/a | n/a | 24.03M | 18.6M | 10.79M | 10.96M | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 88.14M | 93.65M | 208.21M | 105.05M | 115.38M | 125.54M | 135.6M | 113.98M | 118.5M | 123.66M | 157.98M | 128.38M | 106.12M | 122.92M | 128.39M | 130.3M | 103.47M | 110.32M |
Total Liabilities | 183.64M | 206.24M | 319.06M | 210.74M | 220.47M | 223.45M | 250.81M | 205.94M | 218.35M | 227.05M | 284.53M | 259.51M | 229.88M | 249.03M | 254.22M | 227.86M | 177.43M | 171.02M |
Total Debt | 102.59M | 119.25M | 210.2M | 101.62M | 106.3M | 110.86M | 115.35M | 118.34M | 122.33M | 126.13M | 130.7M | 97.65M | 69.56M | 71.82M | 74.02M | 75.98M | 70.67M | 72.74M |
Common Stock | 10K | 10K | 10K | 10K | 10K | 10K | 9K | 9K | 9K | 9K | 9K | 8K | 8K | 8K | 7K | 7K | 7K | 7K |
Retained Earnings | -2.39B | -2.29B | -2.18B | -2.05B | -1.91B | -1.77B | -1.66B | -1.53B | -1.4B | -1.28B | -1.18B | -1.06B | -950.55M | -849.87M | -703M | -621.76M | -550.12M | -481.31M |
Comprehensive Income | 653K | 1.06M | 605K | 3.3M | -1.16M | -947K | -2.26M | -3.57M | -3.87M | -2.68M | -7.46M | -9.37M | -9.55M | -8.06M | -2.63M | -174K | -13K | -12K |
Shareholders Equity | 715.25M | 779.92M | 871.96M | 962.62M | 971.06M | 1.04B | 1.05B | 1.04B | 1.1B | 1.19B | 1.24B | 824.95M | 880.55M | 953.75M | 1.04B | 1.11B | 494.81M | 545.87M |
Total Investments | 500.42M | 604.97M | 456.6M | 854.14M | 822.63M | 795.01M | 839.99M | 854.64M | 777.3M | 680.31M | 811.44M | 776.1M | 841.84M | 949.12M | 1.05B | 876.82M | 421.4M | 459.26M |